Skip to main content
57°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension Challenges
March 05, 2024
Tickers
ALNY
NEWS
RHHBY
Tags
ALNY
RHHBY
General
From
Benzinga
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
February 28, 2024
Tickers
ASML
AZN
GSK
LRLCY
Tags
LRLCY
Top Stories
PPH
From
Benzinga
This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food Allergies
February 26, 2024
Tickers
NEWS
NVS
RHHBY
Tags
NVS
Large Cap
Biotech
From
Benzinga
Move Over Magnificent 7, Say Hello to the GRANOLAS
February 22, 2024
Tickers
AZN
GLAXF
LRLCY
LVMUY
Tags
GLAXF
NVO
LRLCY
From
InvestorPlace
FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight
February 16, 2024
Tickers
NEWS
RHHBY
SRPT
Tags
why it's moving
News
Briefs
From
Benzinga
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
February 15, 2024
Tickers
GLUE
NEWS
RHHBY
Tags
Price Target
Movers
News
From
Benzinga
Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month
February 13, 2024
Tickers
HOOK
NEWS
RHHBY
RPTX
Tags
Stories That Matter
General
RHHBY
From
Benzinga
Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
January 29, 2024
Tickers
GILD
HOOK
MRK
NEWS
Tags
why it is moving
Briefs
News
From
Benzinga
Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In Europe
January 16, 2024
Tickers
HALO
RHHBY
Tags
HALO
Benzinga
Market News
From
Benzinga
Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical Cancer
January 16, 2024
Tickers
MRK
NEWS
RHHBY
Tags
General
RHHBY
News
From
Benzinga
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
January 10, 2024
Tickers
AMGN
AMZN
COR
GOOGL
Tags
AMZN
RHHBY
General
From
Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
January 09, 2024
Tickers
DXCM
RHHBY
SRPT
Tags
SRPT
DXCM
Market News
From
Motley Fool
Why Is LumiraDx (LMDX) Stock Down 13% Today?
January 08, 2024
Tickers
CLRB
HARP
LMDX
RHHBY
Tags
Today's Market
Market News
LMDX
From
InvestorPlace
3 Great Foreign Companies to Invest in Right Now
January 08, 2024
Tickers
ASML
RHHBY
TEAM
Tags
ASML
Market News
Recent Press Releases
From
Motley Fool
Roche Agrees To Purchase Part Of COVID-19 Test Player LumiraDx Diagnostics Platform For $295M
January 02, 2024
Tickers
LMDX
NEWS
RHHBF
RHHBY
Tags
Health Care
Benzinga
Trading Ideas
From
Benzinga
Weighing Their Chances: 5 Leading Healthcare Companies Fight for Market Share in the $100 Billion Weight-Loss Industry
December 21, 2023
Tickers
AZN
LLY
NVO
PFE
Tags
PFE
LLY
NVO
From
Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Tickers
CALT
MCK
NVS
RHHBY
Tags
Expert Ideas
MCK
General
From
Benzinga
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know
December 20, 2023
Tickers
NVDA
RHHBY
Tags
Market News
RHHBY
Recent Press Releases
From
Motley Fool
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
December 15, 2023
Tickers
IPO
IPOS
NVO
RHHBY
Tags
Market News
NVO
Benzinga
From
Benzinga
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
Tickers
INCY
KNSA
NBIX
RHHBY
Tags
NBIX
INCY
KNSA
From
InvestorPlace
Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial
December 11, 2023
Tickers
PSTX
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
Movers
From
Benzinga
Why Viking Therapeutics Was Crushing It This Week
December 08, 2023
Tickers
NVO
RHHBY
VKTX
Tags
Market News
NVO
VKTX
From
Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
December 07, 2023
Tickers
ALT
AZN
LLY
NVO
Tags
ALT
RHHBY
SPX
From
MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
Tickers
ALT
JNJ
LLY
NVO
Tags
News
Briefs
RHHBY
From
Benzinga
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
December 05, 2023
Tickers
ALT
MYNZ
PFE
RHHBY
Tags
ALT
General
RHHBY
From
Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
December 05, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
Health Care
From
Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Tickers
LLY
NVO
RHHBY
Tags
Health Care
Carmot Therapeutics
Roche Holding
From
Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
December 04, 2023
Tickers
LLY
NVO
RHHBF
RHHBY
Tags
RHHVF
RHHBF
M&A
From
Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
Tickers
ABSI
AZN
NVDA
RHHBY
Tags
RHHBY
General
Briefs
From
Benzinga
Ignore Crypto: These Stocks Could Make You Rich
November 23, 2023
Tickers
MDT
NEE
RHHBY
Tags
RHHBY
Recent Press Releases
NEE
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.